Loading candles…
Indoco Remedies, incorporated in 1947 and headquartered in Mumbai, India, is a fully integrated pharmaceutical company operating in both domestic and international markets. The company engages in research and development, manufacturing of active pharmaceutical ingredients (APIs), finished dosage formulations (FDFs), and contract manufacturing. Its products include pharmaceutical formulations and APIs, serving 18 therapeutic segments. Indoco Remedies has a presence in India and exports to over 55 countries, functioning within the pharmaceutical industry.
This page is a live market overview for INDOCO REMEDIES LTD. (INDOCO) on the NSE. As a listed security, INDOCO REMEDIES LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for INDOCO before placing trades on tick2trade.
As of the latest feed, INDOCO last traded at ₹221.73 on NSE, down ₹0.1 (0.05%) from the previous close of ₹221.83. Today's session range is ₹221.04 – ₹224.4, against a 52-week band of ₹162.19 – ₹332.2. Traded volume today stands at 34.17K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for INDOCO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether INDOCO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for INDOCO REMEDIES LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in INDOCO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated INDOCO option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 28 Jul 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 3 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 6 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 24 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 22 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.